Healthy People
0
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Chia Tai TianQing Pharmaceutical GroupChina - Lianyungang
1 programTest preparation：Methylcholine chloroacetate for inhalationPHASE_41 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Chia Tai TianQing Pharmaceutical GroupTest preparation：Methylcholine chloroacetate for inhalation
Qilu PharmaceuticalQL1206
Qilu PharmaceuticalQL1206
Clinical Trials (3)
Total enrollment: 332 patients across 3 trials
NCT06730620Chia Tai TianQing Pharmaceutical GroupTest preparation：Methylcholine chloroacetate for inhalation
Bioequivalence Study of Methacholine Chloride
Start: Jan 2024Est. completion: Feb 202420 patients
Phase 4Completed
Comparing of the Pharmacokinetic, Safety and Pharmacodynamic of QL1206 and Prolia® in Healthy Adults
Start: Oct 2019Est. completion: Oct 2020144 patients
Phase 1Unknown
Comparing of the Pharmacokinetic, Safety and Pharmacodynamic of QL1206 and Xgeva® in Healthy Adults
Start: Aug 2018Est. completion: May 2019168 patients
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.